SCHEMBL19031895

SCHEMBL19031895

CCOC(=O)C(C)(c1ccc(C#N)cn1)C(C#N)C#N

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CNR2 P34972 1/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ HSD11B1 P28845 3/20 0.35
▸ HRH2 P25021 1/20 0.35
▸ HRH1 P35367 1/20 0.35
▸ HRH3 Q9Y5N1 1/20 0.35
▸ PDE10A Q9Y233 1/20 0.35
▸ CCR9 P51686 1/20 0.34
▸ ALDH1A1 P00352 3/20 0.33
▸ IRAK4 Q9NWZ3 2/20 0.33
▸ KDM4E B2RXH2 2/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ PANK3 Q9H999 1/20 0.33
▸ ELANE P08246 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18982673 0.86 CYP2C19 (0.40) MEN1KMT2AHSD11B1CCR9PANK3
SCHEMBL16797513 0.85 SMN1; SMN2 (0.36) SMN1; SMN2MEN1GAAKMT2AALDH1A1
SCHEMBL17318002 0.85 SMN1; SMN2 (0.36) SMN1; SMN2MEN1GAAKMT2ACCR9
SCHEMBL17765327 0.84 GAA (0.36) CNR2SMN1; SMN2MEN1GAAKMT2A
SCHEMBL18982258 0.82 CNR2 (0.40) CNR2SMN1; SMN2HSD11B1HRH2HRH1
SCHEMBL18982796 0.82 HSD11B1 (0.38) CNR2HSD11B1CCR9ALDH1A1KDM4E
SCHEMBL17318012 0.81 KMT2A (0.34) CNR2SMN1; SMN2MEN1GAAKMT2A
SCHEMBL18982556 0.81 CNR2 (0.44) CNR2SMN1; SMN2HRH2HRH1HRH3
SCHEMBL18982196 0.81 CYP4F2 (0.43) SMN1; SMN2MEN1GAAKMT2A
SCHEMBL17768392 0.80 KDM4E (0.37) SMN1; SMN2MEN1GAAKMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3394067-B1 4-AMINO-2-(1H-PYRAZOLO[3,4-B]PYRIDIN-3-YL)-6-OXO-6,7-DIHYDRO-5H-PYRROLO[2,3-D]PYRIMIDINE DERIVATIVES AND THE RESPECTIVE (1H-INDAZOL-3-YL) DERIVATIVES AS CGMP MODULATORS FOR TREATING CARDIOVASCULAR DISEASES MERCK SHARP & DOHME (US) 2020-04-01 — — EP disclosed
EP-3394067-A1 4-AMINO-2-(1H-PYRAZOLO[3,4-B]PYRIDIN-3-YL)-6-OXO-6,7-DIHYDRO-5H-PYRROLO[2,3-D]PYRIMIDINE DERIVATIVES AND THE RESPECTIVE (1H-INDAZOL-3-YL) DERIVATIVES AS CGMP MODULATORS FOR TREATING CARDIOVASCULAR DISEASES Merck Sharp & Dohme Corp. (US) 2018-10-31 — — EP disclosed
WO-2017112617-A1 4-AMINO-2-(1H-PYRAZOLO[3,4-B]PYRIDIN-3-YL)-6-OXO-6,7-DIHYDRO-5H-PYRROLO[2,3-D]PYRIMIDINE DERIVATIVES AND THE RESPECTIVE (1H-INDAZOL-3-YL) DERIVATIVES AS CGMP MODULATORS FOR TREATING CARDIOVASCULAR DISEASES MERCK SHARP & DOHME CORP. (US) 2017-06-29 — — WO disclosed
Send feedback